AMAG Pharmaceuticals (AMAG) Adds Rajiv De Silva and Gino Santini to Board
Down)
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) announced the appointment of Rajiv De Silva and Gino Santini to its board of directors, effective immediately. Mr. De Silva is currently president of Valeant Pharmaceuticals International (NYSE: VRX) and chief operating officer of its Specialty Pharmaceuticals business. Mr. Santini retired in 2010 from a 27-year career at Eli Lilly and Company (NYSE: LLY), where he held a variety of commercial and operational roles, serving most recently as senior vice president, corporate strategy and business development. The appointment of these two independent directors brings the AMAG Board to seven members.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Valeant Pharmaceuticals Agrees to Acquire Certain Assets from Swiss Herbal
- Fred's, Inc. (FRED) Named Steven R. Fitzpatrick to Board of Directors
- H&R Block (HRB) Appoints Greg Macfarlane as CFO
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
